Polymorphisms of ERCC1, XPD, XRCC1 and XPG Predict Clinical Outcome in Advanced Gastric Cancer Patients Receiving Oxaliplatin-Based Chemotherapy in Chinese Population

Polymorphisms of ERCC1, XPD, XRCC1 and XPG Predict Clinical Outcome in Advanced Gastric Cancer Patients Receiving Oxaliplatin-Based Chemotherapy in Chinese Population

OBJECTIVE To investigate whether polymorphisms in ERC1, XPD, XPG, XRCC1 genes are associated with clinical outcomes in advanced gastric cancer (AGC) patients treated with oxaliplatin-based chemotherapy. METHODS The genetic polymorphisms in ERCC1, XPD, XPG, XRCC1 were determined in 94 advan...

Full description

Bibliographic Details
Main Authors: Jian JIANG, Jun LIANG, Ruyong YAO
Format: Article
Language:English
Published: China Anti-Cancer Association 2009-10-01
Series:Cancer Biology & Medicine
Subjects:
gastric cancer
polymorphism
oxaliplatin
chemotherapy
ERCC1
XPD
XPG
XRCC1.
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/232

Similar Items

Similar Items